After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
Monte Rosa Therapeutics Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of Monte Rosa Therapeutics Inc is $642.29M. A total of 1.8 million shares were traded on the day, compared to an average of 1.16M shares.
In the most recent transaction, Dunn Edmund sold 2,062 shares of GLUE for 4.45 per share on Jun 03 ’25. After the transaction, the Principal Accounting Officer now owns 23,732 company shares. In a previous transaction on Mar 24 ’25, Leo Chandra P. bought 10,000 shares at 5.84 per share. GLUE shares that Director owns now total 10,000.
Among the insiders who sold shares, Versant Venture Capital VI, L. disposed of 89,990 shares on Oct 28 ’24 at a per-share price of $9.66. This resulted in the 10% Owner holding 2,007,948 shares of GLUE after the transaction. In another insider transaction, Versant Venture Capital VI, L. sold 67,905 shares at $9.16 per share on Oct 29 ’24. Company shares held by the 10% Owner now total 1,573,453.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, GLUE has a high of $12.40 and a low of $3.50.
As of this writing, GLUE has an earnings estimate of -$0.35 per share for the current quarter. EPS was calculated based on a consensus of 7.0 estimates, with a high estimate of -$0.15 per share and a lower estimate of -$0.46. The company reported an EPS of -$0.29 in the last quarter
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. GLUE’s latest balance sheet shows that the firm has $346.07M in Cash & Short Term Investments as of fiscal 2021. There were $0.00 in debt and $16.64M in liabilities at the time. Its Book Value Per Share was $4.34, while its Total Shareholder’s Equity was $347.51M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock.
